Clinical Research Facility

Englewood, Colorado 80113

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Previously Treated Non Small Cell Lung Cancer Clinical Trial
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
Status: Enrolling, Phase II
Updated: 4/21/2015
mi
from
Englewood, CO
Click here to add this to my saved trials
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer Clinical Trial
Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer
Status: Enrolling, Phase II
Updated: 4/10/2015
mi
from
Englewood, CO
Click here to add this to my saved trials
Gout Clinical Trial
DECT Study in Allopurinol-Treated Gout Patients
Status: Enrolling
Updated: 1/26/2016
mi
from
Englewood, CO
Click here to add this to my saved trials
Pseudomonas Aeruginosa Clinical Trial
Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Englewood, CO
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling, Phase III
Updated: 3/10/2015
mi
from
Englewood, CO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Englewood, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Englewood, CO
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
mi
from
Englewood, CO
Click here to add this to my saved trials